Winter dealmaking adds to pet industry consolidation push
Winter brought a fresh set of pet industry acquisitions, reinforcing that consolidation is still very much in play across pet food, services, and animal health, even if the market is moving more cautiously than it did a few years ago. GlobalPETS pointed to a cluster of deals involving companies such as AlphaPet, Blackstone-backed Rover, and Covetrus. The clearest new development is AlphaPet Ventures’ March 27, 2026 acquisition of Belgian premium dog and cat food brand Cpro Food, which expands the German group’s reach into Belgium and marks its fifth acquisition since 2020. (ad-hoc-news.de)
That deal fits a broader pattern. After the pet M&A surge that followed the pandemic, activity cooled as financing became more expensive and buyers grew more selective. But the strategic rationale never really went away. Industry reporting in 2025 said pet food acquisitions were continuing, just at a slower and more disciplined pace, with buyers favoring businesses that offer premium positioning, operational fit, and defensible growth. S&P Global Market Intelligence likewise found that private equity and venture investment in pet care, food, and supplies jumped sharply in 2023, largely because of Blackstone’s Rover deal, even as 2024 opened more slowly. (petfoodindustry.com)
AlphaPet’s Cpro Food acquisition is a good example of what buyers want now. In its announcement, the company said Cpro Food is a leading super-premium brand in Belgium, with dry food, wet food, and treats sold through specialty retailers and breeders. AlphaPet described the brand as a Belgian “local hero,” language that signals a familiar buy-and-build strategy: acquire established regional brands with loyal followings, then plug them into a larger digital and multichannel platform. The company said Belgium is one of Europe’s pet food markets with a particularly high premium share, making the deal strategically attractive beyond its size alone. (ad-hoc-news.de)
Other recent deals show that the winter M&A story isn’t confined to food. Blackstone completed its approximately $2.3 billion acquisition of Rover on February 27, 2024, taking private one of the largest pet care services marketplaces. In animal health distribution, Patterson Companies announced in January 2025 that it had agreed to be acquired by Patient Square Capital, and Covetrus announced in February 2026 that it plans to merge with MWI Animal Health in a transaction valuing MWI at $3.5 billion. Taken together, those moves suggest buyers still see long-term value in businesses that sit close to pet parents’ recurring spending, whether through food, care services, or veterinary supply chains. (rover.com)
Industry commentary supports that reading. PetfoodIndustry reported that 2025 dealmaking remained active despite caution, citing acquisitions such as Hill’s Pet Nutrition’s move into therapeutic fresh food through Prime100 and the merger of Custom Veterinary Services with Green Mountain Animal to form CompletePet. Analysts cited by S&P Global and IMAP pointed to the same core drivers: pet humanization, premiumization, resilient consumer spending, and investor interest in science-backed or health-oriented categories. In other words, buyers may be slower to write checks, but they’re still looking for assets tied to pet wellness and repeat purchase behavior. (petfoodindustry.com)
Why it matters: For veterinary professionals, these deals are worth watching because consolidation at the industry level can change what shows up in exam rooms and hospital purchasing systems. On the consumer side, acquisitions in premium nutrition may reshape brand portfolios, distribution reach, and marketing claims that pet parents bring into conversations about diet. On the operational side, consolidation among distributors and animal health platforms can affect product availability, service models, pricing dynamics, data flows, and the balance of power between practices and suppliers. Even when a transaction doesn’t directly involve clinics, it can still influence referral patterns, client expectations, and the competitive landscape around preventive care, nutrition, and convenience services. (ad-hoc-news.de)
There’s also a bigger structural takeaway. The pet market’s strongest M&A themes increasingly overlap with veterinary medicine: therapeutic and premium nutrition, supplements, diagnostics, distribution, and service platforms that sit between practices and pet parents. That doesn’t mean every deal will materially affect clinical care, but it does mean business decisions made upstream are more likely to ripple downstream into practice operations and client communication. Veterinary teams may need to pay closer attention to who owns which brands, how supplier relationships are changing, and whether new parent-company strategies alter support, pricing, or product positioning. (petfoodindustry.com)
What to watch: The next question is whether 2026 becomes a true rebound year or simply a steadier continuation of selective consolidation. Expect close attention on add-on acquisitions in premium pet food, health-focused products, and veterinary-adjacent distribution, especially if financing conditions improve and large buyers keep prioritizing assets with recurring demand and clear strategic fit. (imap.com)